401 related articles for article (PubMed ID: 21834778)
21. Recent advances and patents on solid lipid nanoparticles.
Sawant KK; Dodiya SS
Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
[TBL] [Abstract][Full Text] [Related]
22. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
Karwal R; Garg T; Rath G; Markandeywar TS
Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
[TBL] [Abstract][Full Text] [Related]
23. Drug release from liquisolid systems: speed it up, slow it down.
Nokhodchi A; Hentzschel CM; Leopold CS
Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
[TBL] [Abstract][Full Text] [Related]
24. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
25. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
26. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the Literature and Patents on Solid Dispersions from 1980 to 2015.
Zhang J; Han R; Chen W; Zhang W; Li Y; Ji Y; Chen L; Pan H; Yang X; Pan W; Ouyang D
Molecules; 2018 Jul; 23(7):. PubMed ID: 30002275
[No Abstract] [Full Text] [Related]
28. Modulation of Drug Crystallization and Molecular Interactions by Additives in Solid Dispersions for Improving Drug Bioavailability.
Tran PHL; Duan W; Lee BJ; Tran TTD
Curr Pharm Des; 2019; 25(18):2099-2107. PubMed ID: 31244413
[TBL] [Abstract][Full Text] [Related]
29. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.
Salústio PJ; Pontes P; Conduto C; Sanches I; Carvalho C; Arrais J; Marques HM
AAPS PharmSciTech; 2011 Dec; 12(4):1276-92. PubMed ID: 21948320
[TBL] [Abstract][Full Text] [Related]
30. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
[No Abstract] [Full Text] [Related]
32. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.
Chavhan SS; Petkar KC; Sawant KK
Crit Rev Ther Drug Carrier Syst; 2011; 28(5):447-88. PubMed ID: 22077201
[TBL] [Abstract][Full Text] [Related]
33. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
[TBL] [Abstract][Full Text] [Related]
34. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.
Alam MA; Ali R; Al-Jenoobi FI; Al-Mohizea AM
Expert Opin Drug Deliv; 2012 Nov; 9(11):1419-40. PubMed ID: 23043303
[TBL] [Abstract][Full Text] [Related]
35. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
36. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
Thakkar S; Shah V; Misra M; Kalia K
Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
[TBL] [Abstract][Full Text] [Related]
37. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
Kawakami K
Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
[TBL] [Abstract][Full Text] [Related]
38. Nanonization techniques to overcome poor water-solubility with drugs.
Da Silva FLO; Marques MBF; Kato KC; Carneiro G
Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
[TBL] [Abstract][Full Text] [Related]
39. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
40. Drug delivery strategies for poorly water-soluble drugs.
Fahr A; Liu X
Expert Opin Drug Deliv; 2007 Jul; 4(4):403-16. PubMed ID: 17683253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
